Antimicrobial mechanism of theaflavins: They target 1-deoxy-D-xylulose 5-phosphate reductoisomerase, the key enzyme of the MEP terpenoid biosynthetic pathway

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Hui, Xian ^a   Yue, Qiao ^a   Zhang, Dan Dan ^a   Li, Heng ^a   Yang, Shao Qing ^a   Gao, Wen Yun ^a  

^a NORTHWEST UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

1-DEOXY-D-XYLULOSE 5-PHOSPHATE REDUCTOISOMERASE; 2-METHYL-D-ERYTHRITOL-4-PHOSPHATE; ALKALINE PHOSPHATASE; ANTIINFECTIVE AGENT; BIFLAVONOID; CATECHIN; ERYTHRITOL; ISOMERASE; TERPENE; THEAFLAVIN;

ANALOGS AND DERIVATIVES; ANTAGONISTS AND INHIBITORS; CHEMISTRY; DRUG EFFECT; ESCHERICHIA COLI; METABOLISM; MOLECULAR DOCKING; PARTICLE SIZE;

ALDOSE-KETOSE ISOMERASES; ALKALINE PHOSPHATASE; ANTI-BACTERIAL AGENTS; BIFLAVONOIDS; CATECHIN; ERYTHRITOL; ESCHERICHIA COLI; MOLECULAR DOCKING SIMULATION; PARTICLE SIZE; TERPENES;

EID: 85006054862     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep38945     Document Type: Article

References (30)

1. Rohmer, M. In Comprehensive Natural Products II: Chemistry and Biology (eds Mander, L., Liu, H. W. ) 517-556 (Oxford, 2010).
2. Singh, N., Cheve, G., Avery, M. A., McCurdy, C. R. Targeting the MEP pathway for novel antimalarial, antibacterial and herbicidal drug discovery: inhibition of DXR enzyme. Curr. Pharm. Design 13, 1161-1177 (2007).
3. Jomaa, H. et al. Inhibitors of the nonmevalonate pathway of isoprenoid biosynthesis as antimalarial drugs. Science 285, 1573-1576 (1999).
4. Missinou, M. A. et al. Fosmidomycin for malaria. Lancet 360, 1941-1942 (2002).
5. Kaiser, J. et al. Anti-malarial drug targets: Screening for inhibitors of IspC protein in Mediterranean plants. Phytomedicine 14, 242-249 (2007).
6. Friedman, M. Overview of antibacterial, antitoxin, antiviral, and antifungal activities of tea flavonoids and teas. Mol. Nutr. Food Res. 51, 116-134 (2007).
7. Von Staszewski, M., Pilosof, A. M. R., Jagus, R. J. Antioxidant and antimicrobial performance of different Argentinean green tea varieties as affected by whey proteins. Food Chem. 125, 186-192 (2011).
8. Quideau, S., Deffieux, D., Douat-Casassus, C., Pouységu, L. Plant polyphenols: chemical properties, biological activities, and synthesis. Angew. Chem. Int. Ed. 50, 586-621 (2011).
9. de Oliveira, A., Prince, D., Lo, C. Y., Lee, L. H., Chu, T. C. Antiviral activity of theaflavin digallate against herpes simplex virus type 1. Antivir. Res. 118, 56-67 (2015).
10. Halder, B., Pramanick, S., Mukhopadhyay, S., Giri, A. K. Anticlastogenic effects of black tea polyphenols theaflavins and thearubigins in human lymphocytes in vitro. Toxicol. In. vitro. 20, 608-613 (2006).
11. Stoner, G. D., Mukhtar, H. Polyphenols as cancer chemopreventive agents. J. Cell. Biochem. 59, 169-180 (1995).
12. Betts, J. W., Kelly, S. M., Haswell, S. J. Antibacterial effects of theaflavin and synergy with epicatechin againstclinical isolates of Acinetobacter baumannii and Stenotrophomonas maltophilia. Int. J. Antimicrob. Ag. 38, 421-425 (2011).
13. Friedman, M., Henika, P. R., Levin, C. E., Mandrell, R. E., Kozukue, N. Antimicrobial activities of tea catechins and theaflavins and tea extracts against Bacillus cereus. J. Food Prot. 6, 354-361 (2006).
14. Su, Y. L., Leung, L. K., Huang, Y., Chen, Z. Y. Stability of tea theaflavins and catechins. Food Chem. 83, 189-195 (2003).
15. Haymond, A. et al. Kinetic Characterization and Allosteric Inhibition of the Yersinia pestis MEP Synthase. Plos One 9, e106243 (2014).
16. Tritsch, D., Zinglé, C., Rohmer, M., Grosdemange-Billiard, C. Flavonoids: True or promiscuous inhibitors of enzyme? The case of deoxyxylulose phosphate reductoisomerase. Bioorg. Chem. 59, 140-144 (2015).
17. Feng, B. Y., Shoichet, B. K. A detergent-based assay for the detection of promiscuous inhibitors. Nat. Protoc. 1, 550-553 (2006).
18. McGovern, S. L., Helfand, B. T., Feng, B., Shoichet, B. K. A specific mechanism of nonspecific inhibition. J. Med. Chem. 46, 4265-4272 (2003).
19. Zinglé, C., Tritsch, D., Grosdemange-Billiard, C., Michel, R. Catechol-rhodanine derivatives: Specific and promiscuous inhibitors of Escherichia coli DXR. Bioorg. Med. Chem. 22, 3713-3719 (2014).
20. Seidler, J., McGovern, S. L., Doman, T. N., Shoichet, B. K. Identification and prediction of promiscuous aggregating inhibitors among known drugs. J. Med. Chem. 46, 4477-4486 (2003).
21. Pohjala, L., Tammela, P. Aggregating behavior of phenolic compounds-a source of false bioassay results? Molecules 17, 10774-10790 (2012).
22. Cushnie, T. P. T., Lamb, A. J. Recent advances in understanding the antibacterial properties of flavonoids. Int. J. Antimicrob. Ag. 38, 99-107 (2011).
23. McGovern, S. L., Shoichet, B. K. Kinase inhibitors: not just for kinases anymore. J. Med. Chem. 46, 1478-1483 (2003).
24. Rishton G. M. Nonleadlikeness and leadlikeness in biochemical screening. Drug Discov. Today 8, 86-96 (2003).
25. Shoichet, B. K. Screening in a spirit haunted world. Drug Discov. Today 11, 607-615 (2006).
26. Koppisch, A. T., Fox, D. T., Blagg, B. S. J., Poulter, C. D. E. coli MEP synthase: steady-state kinetic analysis and substrate binding. Biochemistry 41, 236-243 (2002).
27. Li, H., Tian, J., Wang, H., Yang, S. Q., Gao, W. Y. An Improved Preparation of D-Glyceraldehyde 3-Phosphate and Its Use in the Synthesis of DXP. Helv. Chim. Acta. 93, 1745-1750 (2010).
28. Li, H., Tian, J., Sun, W., Qin, W., Gao, W. Y. Mechanistic insights into DXR, a key enzyme of the MEP terpenoid biosynthetic pathway. FEBS. J. 280, 5896-5905 (2013).
29. Hu, Y., Wang, X. J., Li, H., GAO, W. Y. Determination of steady-state kinetic parameters of DXS by pre-column derivatization HPLC using 2, 4-Dinitrophenylhydrazine as derivative reagent. Chin. J. Anal. Chem. 40, 1859-1864 (English version) (2012).
30. Sweeney, A. M. et al. The crystal structure of E. coli DXR in a ternary complex with the antimalarial compound fosmidomycin and NADPH reveals a tight-binding closed enzyme conformation. J. Mol. Biol. 345, 115-127 (2005).